## Abstract ## Purpose: To determine histological and MR imaging differences between areas with Gd‐EOB‐DTPA (gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid) uptake and without in hepatocellular carcinomas (HCCs) as seen on Gd‐EOB‐DTPA‐enhanced hepatobiliary‐phase MR images. ## Materi
Gd-EOB-DTPA enhancement pattern of hepatocellular carcinomas in rats: Comparison with Tc-99m-IDA uptake
✍ Scribed by Bernard E. van Beers; Cécile Grandin; Stanislas Pauwels; Isabelle Mottet; Jean-François Goudemant; Monique Delos; Roger Demeure; Jacques Pringot
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- English
- Weight
- 453 KB
- Volume
- 4
- Category
- Article
- ISSN
- 1053-1807
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The enhancement pattern of chemically induced hepatocellular carcinomas (HCCs) after intravenous administration of the hepatobiliary magnetic resonance (MR) contrast agent gadolinium‐EOB‐DTPA (ethoxybenzyl‐diethylenetriaminepentaacetic acid) was compared with the uptake pattern of technetium‐99m‐labeled iminodiacetic acid (IDA), a hepatobiliary radioactive tracer. The hepatocyte uptake of both the contrast agent and the scintigraphic agent has been shown to be driven by the organic anion transporter. The tumors enhanced less than the liver after Gd‐EOB‐DTPA administration, whereas the Tc‐99m‐IDA uptake of differentiated HCCs exceeded that of the liver at 30 minutes and 3 hours after administration. The enhancement pattern of a differentiated HCC with Gd‐EOB‐DTPA does not mirror that seen with Tc‐99m‐IDA.
📜 SIMILAR VOLUMES
## Abstract The purpose of this study was to evaluate the ability of the new liver‐specific magnetic resonance contrast agent gadolinium‐ethoxybenzyl‐diethylenetriamine penta‐acetic acid (Gd‐EOB‐DTPA) to detect hepatocellular carcinoma (HCC). Seventeen mice with 66 chemically induced HCCs underwent